The U.S. is leading the safety needles market in North America and is set to witness a CAGR of 7.5% over the forecast period. The market for safety needles in the Germany is set to expand at a CAGR of 10.6% by the end of 2032 owing to the emergence of established guidelines on infection prevention within a hospital setting
NEWARK, Del, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The global safety needles market size is expected to witness lucrative growth opportunities over the forecast period from 2022 to 2032. The global market was valued at US$ 5,123 Mn in 2021 and is anticipated to touch US$ 11,370 Mn by the end of 2032.
The healthcare sector and hospital pharmacies are expected to lead the global safety needles market on the basis of end users by estimating a valuation of approximately US$ 2.6 Bn by 2021. According to the historical analysis, the global safety needles market is exhibited to grow at a CAGR of 6.3% from 2015 to 2021.
The global market for safety needles accounted for a share of around 62.5% in 2021. Owing surging concerns regarding the transmission of lethal diseases from needle stick injuries have forced several companies to develop innovative needles with enhanced safety features.
Safety needles are equipped with several features in order to prevent needle stick injuries while dispensing medications and collecting bodily fluids. There is a variety of needles such as fine aspiration needles, aspiration & biopsy needles, hypodermic needles, suture needles, IV catheter needles, prefilled needles, and many other varieties of safety needles available on the market.
Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2029
Increasing concerns about needle stick injuries among patients along with healthcare professionals is a prominent factor driving growth in the safety needles market. The rising preference for pain-free needles is expected to create opulent growth opportunities for manufacturers in the global market.
A regular dosage of insulin is crucial for diabetic patients for their well-being and keeping regular track of diabetes, therefore consumers falling in those categories are set to create high demand for painless or pain-free needles to avoid discomfort or unease of painful needles.
The injection safety guidelines (2015) introduced by the World Health Organization (WHO), reveal that for medical workers to use safety-engineered syringes with sharp injury protection/prevention (SIP) must be handled with utmost attention and care.
Rising funding and investments in the surgical instruments department by several hospitals and favorable government initiates have encouraged the use of safe injection practices in order to prevent needle stick injuries & needle re-use, which can further influence the market.
Technological advancements in the safety needles market have gradually bettered medical practices and safety practices by incorporating features like a one-touch needle retraction mechanism, auto-disable feature, reuse prevention, sharp injury protection (SIP), and safety mechanism in only one product/device.
Strict regulations have been implemented by various government agencies in numerous countries concerning the usage of safe needles to avoid hospital-acquired infections like HIV, hepatitis C, and B, which will fuel growth in the global safety needles market throughout the projection years.
Some of the crucial factors propelling growth in the market are due to the prevalence of chronic diseases globally, rising cases of spinal disorders, and the high adoption rate of prefilled syringes. The government is launching new campaigns all over the world to spread awareness about vaccinations among the population. These aforementioned factors are contributing to the expansion of the safety needles market in the future.
Major players in the safety needles market are collaborating with government bodies to raise awareness amongst patients concerning the unsafe use of reusable needles. Mergers and acquisitions in the safety needles market are expected to enhance the product portfolios of various key players during the forecast period.
Medtronic Public Limited Company, Boston Scientific Corp, Becton Dickinson and Company, Smith Medical, Argon Medical Devices, Inc., Novo Nordisk A/S, Terumo Corporation, NIPRO Medical Corporation, B. Braun Melsungen AG., Abbott Laboratories, Eli Lilly and Company, and Retractable Technologies
Read Full Report @ https://www.futuremarketinsights.com/reports/safety-needle-market
Key Segments Covered In Safety Needles Market Report
Spinal Anesthesia and Epidural Needles
Retail Pharmacies & Drug Stores
More Insights into the Safety Needles Market
The U.S. is predicted to dominate the global safety needles market as it garnered a total revenue of about US$ 1.4 Bn in 2021. The market is set to lead the North American region by exhibiting growth at a robust CAGR of 7.5% over the assessment period. The presence of plenty of well-known manufacturers and the surging prevalence of life-threatening diseases in the U.S. are expected to boost growth in the market.
Japan is expected to account for about 8.5% of the global safety needles market. The manufacturing of medical equipment such as biopsy and anesthesia needles have a strong foothold in Japan. With high volumes of production, the country is set to create new growth opportunities for key players in the market for safety needles.
In 2021, Germany possessed 7.6% of the total safety needles market share. The global safety needles market is anticipated to expand over the estimation period at an impressive CAGR of 10.6% due to the emergence of established guidelines on infection prevention within a hospital setting.
Use promo code ->> FMITODAY to get flat 20% discount
2.2. Market Definition / Scope / Limitations
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
Explore FMI’s Extensive Ongoing Coverage on Healthcare Domain
Special Purpose Needles Market Size: Special purpose needles are used in target specific drug deliveries or collection of samples such as fluid and cells from organs or lumps and are available in the market with various advanced features, shapes, and sizes.
Aspiration & Biopsy Needles Market Value: The sales of global Aspiration and Biopsy Needles Market are estimated to reach US$ 1.29 Bn by 2026, registering a growth of 7% over the forecast period 2022 to 2032.
GCC Syringes and Needles Market Forecast: The GCC Syringes and Needles Market was valued at US$ 525.4 Mn in 2020 and is expected to reach US$ 1.33 Bn by 2031, registering a CAGR of 8.8% over the forecast period, from 2021 to 2031, according to a Future Market Insights (FMI) study.
Vertebroplasty Needles Market Analysis: Vertebroplasty is a minimally invasive procedure which is used for treating a compression fracture of the spinal vertebrae in which a special cement is injected into a fractured vertebra by repairing the strength of the collapsed bone and relieving spinal pain.
Needle-Free Vaccine Injectors Market Trends: Growth in the number of communicable disease due to needle stick injuries is one of the major factors driving the growth of the market. Needle free vaccine injectors are basically used in the administration of drugs, vaccines and liquid formulations.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA T: +1-845-579-5705 For Sales Enquiries: sales@futuremarketinsights.com
Below, we share with you three healthcare mutual funds, namely FSHCX, VGHCX and PHLAX. Each has earned a Zacks Mutual Fund Rank #1.
On how businesses are greening their energy mix
Paylocity and three other top-ranked software stocks in the IBD 50 have seen bullish price action in recent weeks.
The Labor Department said the company fired them over suspicions they shared information with The Wall Street Journal. Exxon said it fired them for other reasons and that their allegations were false.
Wall Street fell sharply on Friday following a solid jobs report for September that increased the likelihood the Federal Reserve will barrel ahead with an interest rate hiking campaign many investors fear will push the U.S. economy into a recession. The Labor Department reported the unemployment rate fell to 3.5%, lower than expectations of 3.7%, in an economy that continues to show resilience despite the Fed's efforts to bring down high inflation by weakening growth. Money markets raised to 92% the probability of a fourth straight 75 basis-point rate hike when Fed policymakers meet on Nov. 1-2, up from 83.4% before the data.
Gold futures settled lower on Friday, but notched a second straight weekly gain. A "stronger U.S. jobs report means talks about the [Federal Reserve] potentially pivoting [away from interest-rate hikes] have all but ended," said Fawad Razaqzada, market analyst at City Index and FOREX.com. "The dollar is thus likely to remain supported on the dips, with investors also likely to be discouraged from the stock and gold markets, with the latter particularly looking less attractive because of the fres
What to watch in markets on Friday, October 7, 2022.
(Bloomberg) -- Starbucks Corp. illegally fired a Michigan employee because she engaged in union activism and participated in a US labor board proceeding, a National Labor Relations Board judge ruled.Most Read from BloombergRussia Races to Reopen Crimea Bridge Damaged in Fiery BlastPutin Orders Sakhalin-1 Project Transferred to Russian EntityMinecraft Star Dream Meets His Screaming Fans for First TimeFacebook Is Warning 1 Million Users About Stolen Usernames, PasswordsWall Street Is Missing the R
FedEx Corp (NYSE: FDX) plans to slash the volume outlook for one of its divisions handling e-commerce deliveries. The company arrived at the decision, Reuters reported, as its customers are expected to ship fewer packages during the holiday season. Related: Are FedEx's Troubles Indicative Of A Recession? Perhaps Not For UPS, DHL And Amazon The message was conveyed to the company's 6,000 independent contractors that handle delivery and trucking for FedEx Ground in the U.S. and Canada through an i
California-based Rivian is recalling about 13,000 vehicles after it discovered that a fastener connecting the front upper control arm and steering knuckle may not have been "sufficiently torqued" in some vehicles, a company spokesperson said in a statement. Electric vehicle maker has so far produced a total of 14,317 vehicles this year. Rivian notified the affected customers about the recall after it became aware of seven reports potentially related to the structural issue of torqued fastener, the company said.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Reserve Bank of India will soon commence limited pilot launches of a central bank backed digital rupee for specific use cases, it said in a concept paper released on Friday. The RBI has been exploring the pros and cons of a central bank digital currency for some time and is working towards a strategy to implement it in a phased manner, it said. In February, the Indian government had said that a digital rupee will be launched during the course of this financial year.
Schlumberger saw its IBD SmartSelect Composite Rating rise to 96 Friday, up from 94 the day before. The upgrade means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. Schlumberger is not currently near a proper entry, as it is still building the right side of a cup pattern.
Tilray Brands, Inc. (TLRY) delivered earnings and revenue surprises of -33.33% and 1.59%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Finance ministers from across the world are due to examine crypto regulations next week – but they may shy away from exploring DeFi.
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) will redesign the organization to better focus investments that advance its R&D pipeline, maximize recent commercial launch success, prepare for a potential launch of Roctavian (valoctocogene roxaparvovec) in the U.S., and drive core infrastructure optimization. Biomarin is laying off about 120 employees (or roughly four percent of the global workforce) in a slim down that will save about $50 million annually beginning 2023. Related: BioMarin Says One P
PEP's stock has performed considerably better than the broader market this year and may very well help investors fight inflation.
The deal with Motional marks Uber's (UBER) return to the robotaxi business.
The companies that make up the S&P 500 would already be in a so-called earnings recession this year if it weren’t for higher oil prices.
The 28/36 rule is a rule of thumb for managing your finances and a valuable tool in determining how much house you can afford. The rule says that you should dedicate no more than 28% of your pretax, or gross, … Continue reading → The post What Is the 28/36 Rule in Mortgages? appeared first on SmartAsset Blog.